Acrobiosystems Co.,Ltd. (SHE:301080)
China · Delayed Price · Currency is CNY 41.41
+1.28 (3.19%)
At close: Jun 23, 2026
Acrobiosystems Market Cap
Acrobiosystems has a market cap or net worth of 6.71 billion as of June 23, 2026. Its market cap has increased by 10.70% in one year.
Market Cap
6.71B
Enterprise Value
5.48B
Revenue
887.21M
Ranking
n/a
PE Ratio
38.62
Stock Price
41.41
Market Cap Chart
Since October 18, 2021, Acrobiosystems's market cap has decreased from 13.51B to 6.71B, a decrease of -50.33%. That is a compound annual growth rate of -13.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 6.92B | -23.42% |
| Dec 31, 2025 | 9.04B | 71.05% |
| Dec 31, 2024 | 5.28B | -25.26% |
| Dec 29, 2023 | 7.07B | -13.93% |
| Dec 30, 2022 | 8.22B | -51.36% |
| Dec 31, 2021 | 16.89B | 25.06% |
| Oct 18, 2021 | 13.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Easton Biopharmaceuticals | 7.85B |
| GemPharmatech | 7.82B |
| Daan Gene | 7.79B |
| Shanghai Medicilon | 7.50B |
| Sino Biological,Inc. | 7.37B |
| Bio-Thera Solutions | 7.06B |
| Beijing Hotgen Biotech | 6.82B |
| Zhejiang Ausun Pharmaceutical | 6.70B |